STOKELY DAN 4
4 · Ampio Pharmaceuticals, Inc. · Filed Jun 29, 2021
Insider Transaction Report
Form 4
STOKELY DAN
CFO
Transactions
- Exercise/Conversion
Common Stock
2021-06-25$0.43/sh+22,500$9,675→ 50,815 total - Sale
Common Stock
2021-06-25$1.79/sh−22,500$40,275→ 28,315 total - Exercise/Conversion
1. Stock Option (Right to Buy)
2021-06-25−22,500→ 260,500 totalExercise: $0.43Exp: 2029-08-20→ Common Stock (22,500 underlying)
Footnotes (1)
- [F1]Options were previously reported on a Form 4 dated August 22, 2019, where 50% of the stock option award vested and became exercisable on the date of grant, and the remaining 50% of the stock option award vested and became exercisable on July 31, 2020.